Good post. Emblem is misunderstood (for now) because they are more a pharmaceutical company than cannabis company. Sure, they will take advantage of the recreational market and have just launched the campaign for brand awareness of their adult-use products, but it is the behind the scenes stuff where they are making progress that will be the game-changer.
They aren't relying on the market that will have a short-term run and then see margins erode quickly with oversupply. Emblem has a long-term business model that will give them a piece of the higher-margin medical space. They understand it is the value-added products that will make them successful in the future. It is the pills, capsules, gels, oils, sprays and especially dosage-controlled formulations for sustained release that will set them apart.
One can't compare them to the large companies whose business model is to produce as much as they can and see what happens. Not the game Emblem is playing.
I am happy with where my basis is, but also get it that those who bought much higher are frustrated. Average down at these prices and you will be okay.
The promotional campaign has begun and watch for frequent news and updates now to build momentum. I'm not crying because it is down here... I am rejoicing and buying more. Who doen't like a good sale!
